Published in Medicine and Law Weekly, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at GlaxoSmithKline.
Report 1: Advair HFA Inhalation Aerosol, a new formulation combining fluticasone propionate and salmeterol in a metered-dose inhaler (MDI) delivery device, is now available in pharmacies nationwide.
Advair, a medicine used in the treatment of asthma, became available in 2001 as a dry-powdered inhaler known as Advair Diskus (fluticasone propionate and salmeterol).
Advair HFA offers asthma patients who are unable to use dry-powder...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.